Bristol-Myers Squibb Company
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Asset Breakdown FY2013
Total Assets: $38.59B
Liabilities Breakdown FY2013
Total Liabilities: $23.36B
Asset Breakdown
Total Assets: $38.59B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $3.59B | 9.3% |
| Accounts Receivable | $1.69B | 4.4% |
| Inventory | $1.50B | 3.9% |
| Property, Plant & Equipment | $4.58B | 11.9% |
| Goodwill | $7.10B | 18.4% |
| Intangible Assets | $2.32B | 6.0% |
| Other Assets | $17.83B | 46.2% |
Liabilities Breakdown
Total Liabilities: $23.36B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.56B | 11.0% |
| Long-Term Debt | $7.98B | 34.2% |
| Other Liabilities | $12.82B | 54.9% |